5941153bb7
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
3.1 KiB
3.1 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders | State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders | us/states/md | Maryland General Assembly | 2026 | SB 562 | Maryland SB 562 (2026) |
|
enacted |
|
3 | 13 | 2 | 2026-02-04 | 2026-04-14 | openstates | ocd-bill/f123f942-ccfe-4616-9aef-f8d5d3daff50 | http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0562?ys=2026RS | 8cc110316cad18dcb82089eb10fe378534617b5a0578886783ec85da2a8d4b2c | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Maryland SB 562 (2026) — State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Chapter - State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders (committee substitute) — source
- First - State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders (committee substitute) — source
- Third - State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders (committee substitute) — source
Votes
- On Third Reading — 45–0 (pass) · upper
- On Third Reading — 132–0 (pass) · lower
Sponsors
- Gile — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2026-02-04 First Reading Finance
referral-committee - 2026-02-12 Hearing 3/03 at 1:00 p.m.
- 2026-03-09 Favorable with Amendments Report by Finance
committee-passage-favorable - 2026-03-10 Favorable with Amendments {
committee-passage-favorable - 2026-03-10 Second Reading Passed with Amendments
- 2026-03-12 Third Reading Passed
passage - 2026-03-13 Referred Health
referral-committee - 2026-03-17 Hearing 3/25 at 1:00 p.m.
- 2026-04-01 Favorable Report by Health
committee-passage-favorable - 2026-04-01 Favorable Adopted Second Reading Passed
committee-passage-favorable - 2026-04-02 Third Reading Passed
passage - 2026-04-03 Returned Passed
- 2026-04-14 Approved by the Governor - Chapter 54
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/f123f942-ccfe-4616-9aef-f8d5d3daff50. Confidence: reported (aggregated from official Maryland legislature records).